I am a health economist with ten years experience in academic research and teaching, and experience in the private sector. I was awarded my BA in Economics and Politics in 2008. My undergraduate thesis focused on the electoral performance of populist and extreme right parties in Germany and Austria since German reunification in 1990. I then obtained my MSc in Economics in 2010. My MSc thesis was an empirical study of the relationship between the alcohol consumption of parents and their children using ten years of data from the Health Survey for England.
I joined the University of Manchester in 2010 and have since worked as a Research Associate and Research Fellow in Health Economics. My research has focused on the development and application of evaluation methods for population-level and national interventions in health care delivery, organisation and financing using large administrative datasets (such as HES and CRPD). I have a particular interest in research into vulnerable populations and my PhD thesis focused on econometric analysis of hospital admissions for substance misuse.
I am currently working as a Research Fellow in Health Economics at the University of Manchester, as part of the National Institute for Health Research Applied Research Collaboration (NIHR ARC) for Greater Manchester. I am working with Professor Pete Bower, Professor Jo Dumville and Dr Will Whittaker on the Evaluation Theme, which is initially focused on:
- Delivery of rapid evaluation to support evidence-based innovation in health and care settings
- Enhancing relevance by ensuring research includes patient populations with the greatest need
In addition to this, I am supervising a PhD thesis investigating the cost of illness of Psoriasis; and continuing research in other areas including:
- Methodologies for the evaluation of health and social care financing, organisation and delivery
- Hospital admissions for substance misuse
- Type 2 diabetes and non-diabetic hyperglycemia (pre-diabetes)
- Inequalities in health by sexual identity
- Vulnerable populations including substance misuse, domestic abuse, homelessness and self-harm.
- Micro-costing methodology
- Prediction of anticoagulation control in Atrial Fibrilliation patients treated with Warfarin
- Event study methods applied to diagnoses of cardiac and extra-cardiac symptoms in patients with cardiomyopathies
Memberships of committees and professional bodies
HESG Member (Health Economists' Study Group)
Reviewer (Social Science & Medicine)
Reviewer (Health Policy)
Teaching Assistant (Department of Economics)